GlassScriptPhysician profile
Adam F Meisel
NPI 1184858326
$59,472.45
in general payments reported to CMS, 2019-2025
17 companies · $38K in 2025
The $38K reported for 2025 was more than what 94% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $131 · 2021: $11K · 2022: $1,861 · 2023: $6,888 · 2024: $718 · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $3,891 · Travel and Lodging: $3,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,950.00 |
| Food and Beverage | $3,891.21 |
| Travel and Lodging | $3,338.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $43,964.87 | 2021-2025 | |
| Depuy Synthes Products, INC. | $8,807.68 | 2019-2022 | |
| Stryker Corporation | $2,262.78 | 2023-2025 | Blueprint Patient Specific Instrumentation, T2 Alpha, T2 |
| International Life Sciences | $964.00 | 2023 | |
| Lightbody Medical Technologies INC | $910.52 | 2024-2025 | |
| Medwest Associates | $869.32 | 2021-2023 | |
| Medical Device Business Services, INC. | $603.77 | 2019-2021 | |
| Depuy Synthes Sales INC. | $432.29 | 2019-2024 | Milagro, Intrafix, Dynacord |
| Xiros INC | $196.37 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $113.82 | 2019-2021 | |
| Pacira Therapeutics, INC. | $98.07 | 2019-2021 | |
| Abbott Laboratories | $71.85 | 2019-2025 | Proclaim |
| Ferring Pharmaceuticals INC. | $53.98 | 2019-2023 | Euflexxa |
| Linvatec Corporation | $50.49 | 2023-2024 | Biobrace 23mm |
| Orthofix Medical, INC. | $36.40 | 2022-2025 | Physio-Stim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $23.78 | 2025 | |
| Horizon Therapeutics Plc | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Meisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.